UY28431A1 - Peliculas que se disuelven por via oral - Google Patents
Peliculas que se disuelven por via oralInfo
- Publication number
- UY28431A1 UY28431A1 UY28431A UY28431A UY28431A1 UY 28431 A1 UY28431 A1 UY 28431A1 UY 28431 A UY28431 A UY 28431A UY 28431 A UY28431 A UY 28431A UY 28431 A1 UY28431 A1 UY 28431A1
- Authority
- UY
- Uruguay
- Prior art keywords
- dissolve
- movies
- oral route
- oral
- dissolve rapidly
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
- A61K9/0056—Mouth soluble or dispersible forms; Suckable, eatable, chewable coherent forms; Forms rapidly disintegrating in the mouth; Lozenges; Lollipops; Bite capsules; Baked products; Baits or other oral forms for animals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/4427—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems
- A61K31/4439—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems containing a five-membered ring with nitrogen as a ring hetero atom, e.g. omeprazole
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/465—Nicotine; Derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
- A61K31/716—Glucans
- A61K31/724—Cyclodextrins
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
- A61K47/32—Macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. carbomers, poly(meth)acrylates, or polyvinyl pyrrolidone
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
- A61K9/006—Oral mucosa, e.g. mucoadhesive forms, sublingual droplets; Buccal patches or films; Buccal sprays
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
- A61K9/7007—Drug-containing films, membranes or sheets
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/02—Stomatological preparations, e.g. drugs for caries, aphtae, periodontitis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
- A61P25/34—Tobacco-abuse
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P39/00—General protective or antinoxious agents
- A61P39/02—Antidotes
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Epidemiology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nutrition Science (AREA)
- Physiology (AREA)
- Biomedical Technology (AREA)
- Addiction (AREA)
- Neurosurgery (AREA)
- Neurology (AREA)
- Inorganic Chemistry (AREA)
- Zoology (AREA)
- Molecular Biology (AREA)
- Psychiatry (AREA)
- Toxicology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
- Medicines Containing Plant Substances (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Cosmetics (AREA)
Abstract
Se describen en este documento preparacione orales de película que se disuelven rápidamente para la liberación rápida de un agente activo en la cavidad bucal, en particular, películas orales que se disuelven rápidamente que comprenden un agente activo de nicotina que logra una buena absorción transbucal y que proporciona alivio del ansía de nicotina a un individuo.
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US48985503P | 2003-07-24 | 2003-07-24 |
Publications (1)
Publication Number | Publication Date |
---|---|
UY28431A1 true UY28431A1 (es) | 2005-02-28 |
Family
ID=34102944
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
UY28431A UY28431A1 (es) | 2003-07-24 | 2004-07-22 | Peliculas que se disuelven por via oral |
Country Status (24)
Country | Link |
---|---|
US (1) | US9675548B2 (es) |
EP (2) | EP2446881B1 (es) |
JP (4) | JP2006528636A (es) |
CN (1) | CN100508976C (es) |
AR (1) | AR045076A1 (es) |
AU (2) | AU2004259006B2 (es) |
BR (1) | BRPI0412752B8 (es) |
CA (1) | CA2533577C (es) |
CL (2) | CL2008002406A1 (es) |
DK (2) | DK2446881T3 (es) |
ES (2) | ES2466943T3 (es) |
HK (1) | HK1169802A1 (es) |
HR (1) | HRP20171944T1 (es) |
HU (1) | HUE037508T2 (es) |
LT (1) | LT1648421T (es) |
MX (1) | MXPA06000852A (es) |
PE (1) | PE20050496A1 (es) |
PL (2) | PL2446881T3 (es) |
PT (2) | PT1648421T (es) |
RU (2) | RU2351315C2 (es) |
SI (1) | SI1648421T1 (es) |
TW (1) | TW200514579A (es) |
UY (1) | UY28431A1 (es) |
WO (1) | WO2005009386A2 (es) |
Families Citing this family (107)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US8627828B2 (en) * | 2003-11-07 | 2014-01-14 | U.S. Smokeless Tobacco Company Llc | Tobacco compositions |
EP1691631A4 (en) | 2003-11-07 | 2012-09-05 | Us Smokeless Tobacco Co | TOBACCO COMPOSITIONS |
DE102005033943A1 (de) * | 2005-07-20 | 2007-02-22 | Hexal Ag | Nicht-ausspuckbarer, oraler, schnell-zerfallender Film für ein Neuroleptikum |
DE102005058569B4 (de) * | 2005-12-08 | 2010-07-15 | Lts Lohmann Therapie-Systeme Ag | Schaumwafer mit Polyvinylalkohol-Polyethylenglycol-Pfropfcopolymer |
US7810507B2 (en) | 2006-02-10 | 2010-10-12 | R. J. Reynolds Tobacco Company | Smokeless tobacco composition |
JP5469868B2 (ja) * | 2006-02-17 | 2014-04-16 | ノバルティス アーゲー | 分解可能な口腔フィルム |
US20100015068A1 (en) * | 2006-07-06 | 2010-01-21 | Massachusetts Institute Of Technology | Methods and Compositions For Altering Biological Surfaces |
WO2008080773A1 (de) * | 2006-12-29 | 2008-07-10 | Basf Se | Verfahren zur herstellung von festen dosierungsformen enthaltend pfropfcopolymere |
FR2912915B1 (fr) * | 2007-02-28 | 2012-11-16 | Pf Medicament | Film a desintegration rapide pour l'administration buccale de substances actives. |
JP5784878B2 (ja) * | 2007-03-07 | 2015-09-24 | ノバルティス アーゲー | 経口投与可能なフィルム |
ES2759626T3 (es) * | 2007-05-07 | 2020-05-11 | Evonik Operations Gmbh | Formas farmacéuticas sólidas que comprenden un recubrimiento entérico con liberación acelerada del fármaco |
CN101873809B (zh) | 2007-07-23 | 2014-11-12 | R.J.雷诺兹烟草公司 | 无烟烟草组合物 |
WO2009043588A2 (en) * | 2007-10-02 | 2009-04-09 | LABTEC Gesellschaft für technologische Forschung und Entwicklung mbH | Ph regulating antibacterial films for the oral or vaginal cavity |
MY185299A (en) * | 2007-10-11 | 2021-04-30 | Philip Morris Products Sa | Smokeless tobacco product |
US9125434B2 (en) * | 2007-10-11 | 2015-09-08 | Philip Morris Products S.A. | Smokeless tobacco product, smokeless tobacco product in the form of a sheet, extrudable tobacco composition, method for manufacturing a smokeless tobacco product, method for delivering super bioavailable nicotine contained in tobacco to a user, and packaged smokeless tobacco product sheet |
JP2009102287A (ja) * | 2007-10-19 | 2009-05-14 | Seiji Sakao | 禁煙用の辛い唐辛子 |
WO2009073190A1 (en) * | 2007-12-04 | 2009-06-11 | Swedish Match North America, Inc. | Fast dissolving films and coatings for controlled release of flavors, active pharmaceutical ingredients, food substances, and nicotine |
AU2008334684A1 (en) * | 2007-12-11 | 2009-06-18 | Novartis Ag | Multi-zone films |
DK2229158T3 (en) * | 2007-12-20 | 2016-12-12 | Fertin Pharma As | Compressed chewing gum tablet |
WO2009080021A1 (en) | 2007-12-20 | 2009-07-02 | Fertin Pharma A/S | Compressed chewing gum tablet |
WO2009099831A2 (en) * | 2008-01-31 | 2009-08-13 | Mcneil-Ppc, Inc. | Edible film-strips with modified release active ingredients |
CA2711932A1 (en) * | 2008-01-31 | 2009-08-13 | Mcneil-Ppc, Inc. | Edible film-strips for immediate release of active ingredients |
KR20100117603A (ko) * | 2008-02-13 | 2010-11-03 | 바이엘 쉐링 파마 악티엔게젤샤프트 | 안정화 효과를 갖는 약물 전달 시스템 |
CN104352482A (zh) * | 2008-04-15 | 2015-02-18 | 盐野义制药株式会社 | 膜组合物 |
CA2743329C (en) * | 2008-11-13 | 2020-09-01 | Giuliani International Limited | Antisense compositions and methods of making and using same |
EP2210595A1 (en) * | 2009-01-14 | 2010-07-28 | LEK Pharmaceuticals d.d. | Active coating of pharmaceutical dosage forms |
US20100256215A1 (en) * | 2009-04-02 | 2010-10-07 | Silver Eagle Labs Nv, Llc | Menthol-Melatonin Dissolving Film |
US20100256197A1 (en) * | 2009-04-02 | 2010-10-07 | Silver Eagle Labs Nv, Llc | Nicotine Dissolving Film With Or Without Menthol |
AU2010248060A1 (en) * | 2009-05-12 | 2011-10-27 | Bpsi Holdings, Llc. | Enhanced moisture barrier immediate release film coating systems and substrates coated therewith |
CN102427782A (zh) * | 2009-05-21 | 2012-04-25 | 比奥内克斯制药有限公司 | 双层和单层剂型 |
US8434496B2 (en) | 2009-06-02 | 2013-05-07 | R. J. Reynolds Tobacco Company | Thermal treatment process for tobacco materials |
US8944072B2 (en) | 2009-06-02 | 2015-02-03 | R.J. Reynolds Tobacco Company | Thermal treatment process for tobacco materials |
PL2952191T3 (pl) * | 2009-06-12 | 2019-02-28 | Sunovion Pharmaceuticals Inc. | Apomorfina w postaci do podawania podjęzykowego |
WO2010146601A1 (en) * | 2009-06-15 | 2010-12-23 | Unijules Life Sciences Ltd | Rapid dissolvable oral film for delivering herbal extract/s with or without other pharmaceutically active agents |
US20110139164A1 (en) * | 2009-12-15 | 2011-06-16 | R. J. Reynolds Tobacco Company | Tobacco Product And Method For Manufacture |
US20110220130A1 (en) * | 2009-12-15 | 2011-09-15 | John-Paul Mua | Tobacco Product And Method For Manufacture |
US8955523B2 (en) | 2010-01-15 | 2015-02-17 | R.J. Reynolds Tobacco Company | Tobacco-derived components and materials |
US20130014771A1 (en) | 2011-01-13 | 2013-01-17 | R. J. Reynolds Tobacco Company | Tobacco-derived components and materials |
US8397945B2 (en) | 2010-02-23 | 2013-03-19 | R.J. Reynolds Tobacco Company | Dispensing container |
RU2560693C2 (ru) * | 2010-03-23 | 2015-08-20 | Апр Эпплайд Фарма Рисерч, С.А. | Быстро растворяющиеся системы, освобождающие лекарственные препараты |
US9039839B2 (en) | 2010-04-08 | 2015-05-26 | R.J. Reynolds Tobacco Company | Smokeless tobacco composition comprising tobacco-derived material and non-tobacco plant material |
US10327467B2 (en) | 2010-04-14 | 2019-06-25 | Altria Client Services Llc | Preformed smokeless tobacco product |
US9402415B2 (en) | 2010-04-21 | 2016-08-02 | R. J. Reynolds Tobacco Company | Tobacco seed-derived components and materials |
EP2563344A1 (en) * | 2010-04-27 | 2013-03-06 | Novartis AG | Oral dosage forms |
US20110268809A1 (en) | 2010-04-28 | 2011-11-03 | Paul Andrew Brinkley | Nicotine-Containing Pharmaceutical Compositions |
US20110274628A1 (en) | 2010-05-07 | 2011-11-10 | Borschke August J | Nicotine-containing pharmaceutical compositions |
US9675102B2 (en) | 2010-09-07 | 2017-06-13 | R. J. Reynolds Tobacco Company | Smokeless tobacco product comprising effervescent composition |
DE102010048408A1 (de) | 2010-10-15 | 2012-04-19 | Lts Lohmann Therapie-Systeme Ag | Laminat mit verbessertem Wasserretentionsverhalten |
US20120125354A1 (en) | 2010-11-18 | 2012-05-24 | R.J. Reynolds Tobacco Company | Fire-Cured Tobacco Extract and Tobacco Products Made Therefrom |
WO2012083269A1 (en) | 2010-12-16 | 2012-06-21 | Cynapsus Therapeutics, Inc. | Sublingual films |
US20120152265A1 (en) | 2010-12-17 | 2012-06-21 | R.J. Reynolds Tobacco Company | Tobacco-Derived Syrup Composition |
US9107453B2 (en) | 2011-01-28 | 2015-08-18 | R.J. Reynolds Tobacco Company | Tobacco-derived casing composition |
US8893725B2 (en) | 2011-01-28 | 2014-11-25 | R. J. Reynolds Tobacco Company | Polymeric materials derived from tobacco |
US9254001B2 (en) | 2011-04-27 | 2016-02-09 | R.J. Reynolds Tobacco Company | Tobacco-derived components and materials |
US9192193B2 (en) | 2011-05-19 | 2015-11-24 | R.J. Reynolds Tobacco Company | Molecularly imprinted polymers for treating tobacco material and filtering smoke from smoking articles |
US20130078307A1 (en) | 2011-09-22 | 2013-03-28 | Niconovum Usa, Inc. | Nicotine-containing pharmaceutical composition |
EP3108876A1 (en) * | 2011-10-13 | 2016-12-28 | Jaleva Pharmaceuticals LLC | Methods and compositions for rapid transbuccal delivery of active agents |
US9907748B2 (en) | 2011-10-21 | 2018-03-06 | Niconovum Usa, Inc. | Excipients for nicotine-containing therapeutic compositions |
US20130125907A1 (en) | 2011-11-17 | 2013-05-23 | Michael Francis Dube | Method for Producing Triethyl Citrate from Tobacco |
US10881132B2 (en) | 2011-12-14 | 2021-01-05 | R.J. Reynolds Tobacco Company | Smokeless tobacco product comprising effervescent composition |
US9763928B2 (en) | 2012-02-10 | 2017-09-19 | Niconovum Usa, Inc. | Multi-layer nicotine-containing pharmaceutical composition |
CN104284605B (zh) | 2012-03-19 | 2018-02-23 | R.J.雷诺兹烟草公司 | 用于处理提取的烟草浆的方法和由此制备的烟草产品 |
US10799451B2 (en) * | 2012-03-27 | 2020-10-13 | Nicoccino Ab | Nicotine formulation |
EP2874824A1 (en) | 2012-07-23 | 2015-05-27 | Crayola LLC | Dissolvable films and methods of using the same |
WO2014059284A1 (en) * | 2012-10-12 | 2014-04-17 | Jaleva Pharmaceuticals, Llc | Method of preparing resin tinctures |
WO2014085445A1 (en) | 2012-11-28 | 2014-06-05 | Jaleva Pharmaceuticals, Llc | Dual chamber applicator |
US20140166027A1 (en) * | 2012-12-14 | 2014-06-19 | Richard C. Fuisz | Enhanced Delivery of Nicotine, THC, Tobacco, Cannabidiol or Base Alkaloid from an Electronic Cigarette or Other Vapor Producing Device Through Use of an Absorption Conditioning Unit |
US20140166028A1 (en) * | 2012-12-14 | 2014-06-19 | Richard C. Fuisz | Enhanced Delivery of Nicotine, THC, Tobacco, Cannabidiol or Base Alkaloid from an Electronic Cigarette or Other Vapor or Smoke Producing Device Through Use of an Absorption Conditioning Unit |
US9289011B2 (en) | 2013-03-07 | 2016-03-22 | R.J. Reynolds Tobacco Company | Method for producing lutein from tobacco |
EP2968196A2 (en) | 2013-03-14 | 2016-01-20 | Altria Client Services LLC | Soft oral product |
US10799548B2 (en) * | 2013-03-15 | 2020-10-13 | Altria Client Services Llc | Modifying taste and sensory irritation of smokeless tobacco and non-tobacco products |
US20140275148A1 (en) * | 2013-03-15 | 2014-09-18 | Novus Pharma LLC | Orally administrable, self-supporting dissolving film dosage forms |
US20160101108A1 (en) * | 2013-05-23 | 2016-04-14 | Åbo Akademi University | Printed dosage forms |
US20150034109A1 (en) | 2013-08-02 | 2015-02-05 | R.J. Reynolds Tobacco Company | Process for Producing Lignin from Tobacco |
US11503853B2 (en) | 2013-09-09 | 2022-11-22 | R.J. Reynolds Tobacco Company | Smokeless tobacco composition incorporating a botanical material |
CN105530998B (zh) * | 2013-09-11 | 2018-09-21 | 3M创新有限公司 | 口腔组合物 |
US10357054B2 (en) | 2013-10-16 | 2019-07-23 | R.J. Reynolds Tobacco Company | Smokeless tobacco pastille |
US20150147555A1 (en) * | 2013-11-23 | 2015-05-28 | Orahealth Corporation | Multilayer mucoadhering patch with a nonadhering layer comprising casein |
US20160303242A1 (en) | 2013-12-09 | 2016-10-20 | Durect Corporation | Pharmaceutically Active Agent Complexes, Polymer Complexes, and Compositions and Methods Involving the Same |
ES2703210T3 (es) | 2013-12-31 | 2019-03-07 | Johnson & Johnson Consumer Inc | Proceso en un solo paso para la formación de un producto en la forma de película de capas múltiples, producto y aparato |
JP6636431B2 (ja) | 2013-12-31 | 2020-01-29 | ジョンソン・アンド・ジョンソン・コンシューマー・インコーポレイテッド | 賦形フィルム製品を形成するための方法 |
KR102240525B1 (ko) | 2013-12-31 | 2021-04-16 | 존슨 앤드 존슨 컨수머 인코포레이티드 | 다층의 형상화된 필름을 형성하기 위한 방법 |
US9265284B2 (en) | 2014-01-17 | 2016-02-23 | R.J. Reynolds Tobacco Company | Process for producing flavorants and related materials |
CA2969466A1 (en) * | 2014-12-09 | 2016-06-16 | Monosolrx Llc | Linear polysaccharide based film products |
DE102015201871B4 (de) * | 2015-02-03 | 2018-04-05 | Ferton Holding S.A. | Verwendung eines Pulvers als Mittel zur Pulverstrahlbearbeitung in einem Pulverstrahlgerät und Verfahren zur Reinigung von Zähnen |
US10881133B2 (en) | 2015-04-16 | 2021-01-05 | R.J. Reynolds Tobacco Company | Tobacco-derived cellulosic sugar |
CA3019769C (en) | 2015-04-21 | 2021-10-12 | Sunovion Pharmaceuticals Inc. | Methods of treating parkinson's disease by administration of apomorphine to an oral mucosa |
US20170059554A1 (en) | 2015-09-02 | 2017-03-02 | R. J. Reynolds Tobacco Company | Method for monitoring use of a tobacco product |
ITUB20153446A1 (it) * | 2015-09-07 | 2017-03-07 | Pharmafilm Srl | Film orodispersibili a rapida disgregazione per uso terapeutico o alimentare |
US10869497B2 (en) | 2015-09-08 | 2020-12-22 | R.J. Reynolds Tobacco Company | High-pressure cold pasteurization of tobacco material |
US10532046B2 (en) | 2015-12-03 | 2020-01-14 | Niconovum Usa, Inc. | Multi-phase delivery compositions and products incorporating such compositions |
US20170165252A1 (en) | 2015-12-10 | 2017-06-15 | Niconovum Usa Inc. | Protein-enriched therapeutic composition |
US10499684B2 (en) | 2016-01-28 | 2019-12-10 | R.J. Reynolds Tobacco Company | Tobacco-derived flavorants |
US11154087B2 (en) | 2016-02-02 | 2021-10-26 | R.J. Reynolds Tobacco Company | Method for preparing flavorful compounds isolated from black liquor and products incorporating the flavorful compounds |
WO2017214187A1 (en) * | 2016-06-07 | 2017-12-14 | Aridis Pharmaceuticals, Inc. | Method for preparation of quick dissolving thin films containing bioactive material with enhanced thermal stability |
IL247161A0 (en) * | 2016-08-08 | 2016-12-29 | Rubin Yoram | Fast-dissolving adhesive films for the treatment of oral conditions |
US11091446B2 (en) | 2017-03-24 | 2021-08-17 | R.J. Reynolds Tobacco Company | Methods of selectively forming substituted pyrazines |
AU2018378648B2 (en) | 2017-12-08 | 2021-06-03 | Fertin Pharma A/S | Nicotine tablet |
US20190307082A1 (en) | 2018-04-05 | 2019-10-10 | R.J. Reynolds Tobacco Company | Oriental tobacco production methods |
WO2019204708A1 (en) * | 2018-04-21 | 2019-10-24 | Quest Products, Llc | Bilayer adhering lozenge effective to mask undesirable flavor |
BR112020025604A2 (pt) | 2018-06-15 | 2021-03-23 | R.J. Reynolds Tobacco Company | purificação de nicotina |
WO2019244176A1 (en) * | 2018-06-23 | 2019-12-26 | Strides Shasun Limited | Stable nicotine lozenges |
US11235013B2 (en) | 2018-09-04 | 2022-02-01 | Babak Ghalili | Cannabinoid, menthol and caffeine dissolvable film compositions, devices and methods |
JP7361547B2 (ja) | 2019-09-10 | 2023-10-16 | 三菱電機ビルソリューションズ株式会社 | ロボットシステム |
WO2021177941A1 (en) * | 2020-03-03 | 2021-09-10 | Babak Ghalili | Cannabinoid, menthol and caffeine dissolvable film compositions, devices and methods |
EP4326095A1 (en) * | 2021-04-22 | 2024-02-28 | Nicoventures Trading Limited | Orally dissolving films |
WO2024037043A1 (zh) * | 2023-04-28 | 2024-02-22 | 深圳华宝协同创新技术研究院有限公司 | 用于口腔粘膜的包含尼古丁的薄膜组合物 |
Family Cites Families (92)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5288498A (en) | 1985-05-01 | 1994-02-22 | University Of Utah Research Foundation | Compositions of oral nondissolvable matrixes for transmucosal administration of medicaments |
JPH0729915B2 (ja) | 1986-02-01 | 1995-04-05 | 帝國製薬株式会社 | シ−ト状口腔内貼付剤 |
JPS62223112A (ja) * | 1986-03-25 | 1987-10-01 | Rooto Seiyaku Kk | 歯周病治療剤 |
DE3827561C1 (es) * | 1988-08-13 | 1989-12-28 | Lts Lohmann Therapie-Systeme Gmbh & Co Kg, 5450 Neuwied, De | |
DE4310012A1 (de) | 1993-03-27 | 1994-09-29 | Roehm Gmbh | Dermales therapeutisches System aus einer schmelzfähigen Poly(meth)acrylat-Mischung |
DE69422925T2 (de) | 1993-07-09 | 2000-08-17 | Cygnus Therapeutic Systems | Verfahren und vorrichtung für die transdermale oder transbuccale therapeutische verabreichung von nikotinsubstituten |
SG93789A1 (en) | 1994-03-16 | 2003-01-21 | Xaar Ltd | Improvements relating to pulsed droplet deposition apparatus |
AU2703795A (en) | 1994-06-23 | 1996-01-19 | Procter & Gamble Company, The | Treatment of nicotine craving and/or smoking withdrawal symptoms with a transdermal or transmucosal composition containing nicotine and caffeine or xanthine |
US5508276A (en) * | 1994-07-18 | 1996-04-16 | Eli Lilly And Company | Duloxetine enteric pellets |
WO1996022083A1 (en) | 1995-01-19 | 1996-07-25 | Cygnus, Inc. | POLYISOBUTYLENE ADHESIVES CONTAINING HIGH Tg TACKIFIER FOR TRANSDERMAL DEVICES |
JPH08245423A (ja) | 1995-03-06 | 1996-09-24 | Shionogi & Co Ltd | 水系腸溶性コーティング液 |
ES2206709T3 (es) * | 1996-05-13 | 2004-05-16 | Novartis Consumer Health S.A. | Sistema de suministro bucal. |
US6623759B2 (en) | 1996-06-28 | 2003-09-23 | Astrazeneca Ab | Stable drug form for oral administration with benzimidazole derivatives as active ingredient and process for the preparation thereof |
DE19626045C2 (de) * | 1996-06-28 | 1998-12-03 | Klinge Co Chem Pharm Fab | Stabile Arzneiform zur oralen Verabreichung, welche Omeprazol als aktiven Wirkstoff enthält, sowie Verfahren zur Herstellung derselben |
GB9614902D0 (en) | 1996-07-16 | 1996-09-04 | Rhodes John | Sustained release composition |
DE19646392A1 (de) | 1996-11-11 | 1998-05-14 | Lohmann Therapie Syst Lts | Zubereitung zur Anwendung in der Mundhöhle mit einer an der Schleimhaut haftklebenden, Pharmazeutika oder Kosmetika zur dosierten Abgabe enthaltenden Schicht |
DE19653605C2 (de) | 1996-12-20 | 2002-11-28 | Roehm Gmbh | Haft- und Bindemittel für dermale oder transdermale Therapiesysteme und dessen Verwendung zur Herstellung eines transdermalen Therapiesystems |
ATE356139T1 (de) * | 1997-06-25 | 2007-03-15 | Pfizer | Dipeptidderivate zur förderung der sekretion von wachstumshormon |
US6197331B1 (en) * | 1997-07-24 | 2001-03-06 | Perio Products Ltd. | Pharmaceutical oral patch for controlled release of pharmaceutical agents in the oral cavity |
US20030176467A1 (en) | 1997-09-25 | 2003-09-18 | Sven Andersson | Nicotine compositions |
JP3460538B2 (ja) | 1997-10-08 | 2003-10-27 | 救急薬品工業株式会社 | 速溶性フィルム製剤 |
US6096340A (en) * | 1997-11-14 | 2000-08-01 | Andrx Pharmaceuticals, Inc. | Omeprazole formulation |
EP1357109B1 (en) | 1998-06-18 | 2008-07-23 | F. Hoffmann-La Roche Ag | Process for aryl alkyl sulfide |
US6358060B2 (en) | 1998-09-03 | 2002-03-19 | Jsr Llc | Two-stage transmucosal medicine delivery system for symptom relief |
US6596298B2 (en) | 1998-09-25 | 2003-07-22 | Warner-Lambert Company | Fast dissolving orally comsumable films |
US20030170195A1 (en) | 2000-01-10 | 2003-09-11 | Noven Pharmaceuticals, Inc. | Compositions and methods for drug delivery |
AU3470600A (en) | 1999-01-14 | 2000-08-01 | David Houze | Compositions and methods for drug delivery |
US6552024B1 (en) | 1999-01-21 | 2003-04-22 | Lavipharm Laboratories Inc. | Compositions and methods for mucosal delivery |
US6248760B1 (en) | 1999-04-14 | 2001-06-19 | Paul C Wilhelmsen | Tablet giving rapid release of nicotine for transmucosal administration |
US6264981B1 (en) | 1999-10-27 | 2001-07-24 | Anesta Corporation | Oral transmucosal drug dosage using solid solution |
US6420473B1 (en) | 2000-02-10 | 2002-07-16 | Bpsi Holdings, Inc. | Acrylic enteric coating compositions |
US7067116B1 (en) | 2000-03-23 | 2006-06-27 | Warner-Lambert Company Llc | Fast dissolving orally consumable solid film containing a taste masking agent and pharmaceutically active agent at weight ratio of 1:3 to 3:1 |
KR100452972B1 (ko) | 2000-05-16 | 2004-10-14 | 주식회사 삼양사 | 경피투여용 하이드로젤 조성물 |
JP4555436B2 (ja) | 2000-06-29 | 2010-09-29 | 富士通株式会社 | 薄膜樹脂基板への樹脂モールド方法及び高周波モジュール |
DE10032456A1 (de) | 2000-07-04 | 2002-01-31 | Lohmann Therapie Syst Lts | Schnell zerfallende Darreichungsform zur Freisetzung von Wirkstoffen im Mundraum oder in Körperhöhlen |
US8566211B2 (en) | 2000-11-22 | 2013-10-22 | Efficient Auctions, Llc | System and method for a dynamic auction with package bidding |
US20020131990A1 (en) | 2000-11-30 | 2002-09-19 | Barkalow David G. | Pullulan free edible film compositions and methods of making the same |
US6479076B2 (en) | 2001-01-12 | 2002-11-12 | Izhak Blank | Nicotine delivery compositions |
DE10110391A1 (de) | 2001-03-03 | 2002-09-26 | Lohmann Therapie Syst Lts | Hochflexibles Nikotin transdermales therapeutisches System mit Nikotin als Wirkstoff |
CN101301275A (zh) * | 2001-03-26 | 2008-11-12 | 史密丝克莱恩比彻姆公司 | 含烟碱的口服剂量形式的制备方法 |
EP1389910A4 (en) | 2001-04-20 | 2005-11-02 | Lavipharm Lab Inc | INTRABUCAL DISTRIBUTION OF NICOTINE INTENDED TO STOP SMOKING |
ATE480226T1 (de) * | 2001-06-22 | 2010-09-15 | Bend Res Inc | Pharmazeutische zusammensetzung enthaltend schwer lösliche und säureempfindliche arzneistoffe und neutralisierte anionische polymere |
US20030118653A1 (en) | 2001-07-06 | 2003-06-26 | Lavipharm Laboratories Inc. | Quick dissolving oral mucosal drug delivery device with moisture barrier coating |
DE10141652B4 (de) | 2001-08-24 | 2011-04-07 | Lts Lohmann Therapie-Systeme Ag | Transdermales therapeutisches System auf der Basis von Polyacrylat-Haftklebern ohne funktionelle Gruppen und seine Verwendung |
US20030092724A1 (en) | 2001-09-18 | 2003-05-15 | Huaihung Kao | Combination sustained release-immediate release oral dosage forms with an opioid analgesic and a non-opioid analgesic |
JP5089840B2 (ja) * | 2001-09-25 | 2012-12-05 | 救急薬品工業株式会社 | ニコチン含有フィルム製剤 |
US20040213848A1 (en) * | 2001-09-28 | 2004-10-28 | Shun-Por Li | Modified release dosage forms |
US7425292B2 (en) | 2001-10-12 | 2008-09-16 | Monosol Rx, Llc | Thin film with non-self-aggregating uniform heterogeneity and drug delivery systems made therefrom |
US20040037879A1 (en) * | 2001-11-02 | 2004-02-26 | Adusumilli Prasad S. | Oral controlled release forms useful for reducing or preventing nicotine cravings |
JP2003213038A (ja) | 2001-11-16 | 2003-07-30 | Natl Starch & Chem Investment Holding Corp | デンプンを含有するフィルム |
US20030099691A1 (en) | 2001-11-16 | 2003-05-29 | Susan Lydzinski | Films containing starch |
DE10224612A1 (de) * | 2002-06-04 | 2003-12-24 | Lohmann Therapie Syst Lts | Wirkstoffhaltige filmförmige Zubereitungen mit verbesserter chemischer Stabilität, und Verfahren zu deren Herstellung |
US20040013752A1 (en) | 2002-07-05 | 2004-01-22 | Wolfson Philip E. | Buccal and sublingual mucosally absorbed herbal compositions for relieving nicotine withdrawal symptoms and craving for nicotine and nicotine containing substances |
US8216609B2 (en) | 2002-08-05 | 2012-07-10 | Torrent Pharmaceuticals Limited | Modified release composition of highly soluble drugs |
US8268352B2 (en) | 2002-08-05 | 2012-09-18 | Torrent Pharmaceuticals Limited | Modified release composition for highly soluble drugs |
US20030049307A1 (en) | 2002-08-15 | 2003-03-13 | Gyurik Robert J. | Pharmaceutical composition |
DE10256775A1 (de) | 2002-12-05 | 2004-06-24 | Lts Lohmann Therapie-Systeme Ag | Filmförmige Zubereitungen zur transmucosalen Verabreichung von Nicotin, sowie Verfahren zu deren Herstellung |
KR20050096922A (ko) | 2002-12-20 | 2005-10-06 | 니코노범 에이비 | 물리적 및 화학적으로 안정된 니코틴 함유 입자물질 |
US20040208931A1 (en) | 2002-12-30 | 2004-10-21 | Friend David R | Fast dissolving films for oral administration of drugs |
WO2005004989A2 (en) | 2003-07-01 | 2005-01-20 | Todd Maibach | Film comprising therapeutic agents |
DE10338544B4 (de) | 2003-08-19 | 2017-08-31 | Janssen Pharmaceutica N.V. | Buccale Formulierungen des Galanthamins und deren Anwendungen |
KR20050048056A (ko) | 2003-11-18 | 2005-05-24 | (주)케이비피 | 경구용 소모 필름 조성물 |
DE10354894A1 (de) | 2003-11-24 | 2005-07-07 | Hf Arzneimittelforschung Gmbh | Orale Formulierungen des Desoxypeganins und deren Anwendungen |
US20050181050A1 (en) | 2004-01-28 | 2005-08-18 | Collegium Pharmaceutical, Inc. | Dosage forms using drug-loaded ion exchange resins |
WO2005115336A2 (en) | 2004-05-15 | 2005-12-08 | Collegium Pharmaceutical, Inc. | Sprayable formulations for the treatment of acute inflammatory skin conditions |
US8907153B2 (en) | 2004-06-07 | 2014-12-09 | Nuvo Research Inc. | Adhesive peel-forming formulations for dermal delivery of drugs and methods of using the same |
US20060046962A1 (en) | 2004-08-25 | 2006-03-02 | Aegis Therapeutics Llc | Absorption enhancers for drug administration |
EP1789075A4 (en) | 2004-08-25 | 2009-07-01 | Uab Research Foundation | ABSORPTION ENHANCER FOR DRUG ADMINISTRATION |
US20060046969A1 (en) | 2004-08-25 | 2006-03-02 | Aegis Therapeutics Llc | Antibacterial compositions for drug administration |
EP1807033B1 (en) | 2004-10-08 | 2016-07-20 | Noven Pharmaceuticals, Inc. | Transdermal drug delivery device including an occlusive backing |
WO2006040680A1 (en) | 2004-10-15 | 2006-04-20 | Pfizer Products Inc. | Compositions and methods for intranasal, buccal, sublingual and pulmonary delivery of varenicline |
GB0508306D0 (en) | 2005-04-25 | 2005-06-01 | Bioprogress Technology Ltd | Nicotine dosage forms |
JP5000932B2 (ja) | 2005-06-21 | 2012-08-15 | 日東電工株式会社 | ニコチン含有経皮吸収製剤 |
JP5469868B2 (ja) | 2006-02-17 | 2014-04-16 | ノバルティス アーゲー | 分解可能な口腔フィルム |
US20070269386A1 (en) | 2006-05-16 | 2007-11-22 | Per Steen | New product and use and manufacture thereof |
US20100028447A1 (en) | 2007-01-22 | 2010-02-04 | Targacept, Inc. | Intranasal, Buccal, And Sublingual Administration Of Metanicotine Analogs |
FR2912915B1 (fr) | 2007-02-28 | 2012-11-16 | Pf Medicament | Film a desintegration rapide pour l'administration buccale de substances actives. |
JP5784878B2 (ja) | 2007-03-07 | 2015-09-24 | ノバルティス アーゲー | 経口投与可能なフィルム |
US20080286340A1 (en) | 2007-05-16 | 2008-11-20 | Sven-Borje Andersson | Buffered nicotine containing products |
US20080292683A1 (en) | 2007-05-24 | 2008-11-27 | Monosolrx, Llc. | Film shreds and delivery system incorporating same |
KR101405930B1 (ko) * | 2007-07-05 | 2014-06-12 | 엘지전자 주식회사 | 식기 세척기의 제어방법 |
US20090081294A1 (en) | 2007-09-26 | 2009-03-26 | Gin Jerry B | Sustained release dosage form for lubricating an oral cavity |
WO2009045022A2 (en) | 2007-10-03 | 2009-04-09 | C.L. Pharm | Edible film |
KR100905027B1 (ko) | 2007-10-03 | 2009-06-30 | (주)씨엘팜 | 식용 필름 |
WO2009073190A1 (en) | 2007-12-04 | 2009-06-11 | Swedish Match North America, Inc. | Fast dissolving films and coatings for controlled release of flavors, active pharmaceutical ingredients, food substances, and nicotine |
AU2008334684A1 (en) | 2007-12-11 | 2009-06-18 | Novartis Ag | Multi-zone films |
WO2010044736A1 (en) | 2008-10-14 | 2010-04-22 | Mcneil Ab | Multi portion intra-oral dosage form and use thereof |
US20100247586A1 (en) | 2009-03-27 | 2010-09-30 | Andreas Hugerth | Multi-Portion Intra-Oral Dosage Form With Organoleptic Properties |
KR101074271B1 (ko) | 2009-06-25 | 2011-10-17 | (주)차바이오앤디오스텍 | 불쾌한 맛을 효과적으로 은폐한 경구용 속용 필름 |
PT2519225E (pt) | 2009-12-30 | 2015-07-27 | Novartis Ag | Tiras finas de nicotina extrudidas por fusão |
EP2563344A1 (en) | 2010-04-27 | 2013-03-06 | Novartis AG | Oral dosage forms |
AU2011306050A1 (en) | 2010-09-24 | 2013-04-11 | Nexmed Holdings, Inc. | Enhanced transbuccal drug delivery system and compositions |
-
2004
- 2004-07-22 AR ARP040102603A patent/AR045076A1/es unknown
- 2004-07-22 US US10/565,706 patent/US9675548B2/en active Active
- 2004-07-22 HU HUE04778981A patent/HUE037508T2/hu unknown
- 2004-07-22 EP EP12152301.3A patent/EP2446881B1/en active Active
- 2004-07-22 ES ES12152301.3T patent/ES2466943T3/es active Active
- 2004-07-22 EP EP04778981.3A patent/EP1648421B1/en active Active
- 2004-07-22 DK DK12152301.3T patent/DK2446881T3/da active
- 2004-07-22 LT LTEP04778981.3T patent/LT1648421T/lt unknown
- 2004-07-22 CA CA2533577A patent/CA2533577C/en active Active
- 2004-07-22 ES ES04778981.3T patent/ES2654062T3/es active Active
- 2004-07-22 PT PT47789813T patent/PT1648421T/pt unknown
- 2004-07-22 BR BRPI0412752A patent/BRPI0412752B8/pt active IP Right Grant
- 2004-07-22 RU RU2006105630/15A patent/RU2351315C2/ru active
- 2004-07-22 MX MXPA06000852A patent/MXPA06000852A/es unknown
- 2004-07-22 PL PL12152301T patent/PL2446881T3/pl unknown
- 2004-07-22 PT PT121523013T patent/PT2446881E/pt unknown
- 2004-07-22 PL PL04778981T patent/PL1648421T3/pl unknown
- 2004-07-22 DK DK04778981.3T patent/DK1648421T3/en active
- 2004-07-22 CN CNB2004800213483A patent/CN100508976C/zh active Active
- 2004-07-22 AU AU2004259006A patent/AU2004259006B2/en active Active
- 2004-07-22 TW TW093121830A patent/TW200514579A/zh unknown
- 2004-07-22 PE PE2004000696A patent/PE20050496A1/es active IP Right Grant
- 2004-07-22 WO PCT/US2004/023719 patent/WO2005009386A2/en active Application Filing
- 2004-07-22 SI SI200432422T patent/SI1648421T1/en unknown
- 2004-07-22 JP JP2006521266A patent/JP2006528636A/ja active Pending
- 2004-07-22 UY UY28431A patent/UY28431A1/es unknown
-
2008
- 2008-01-14 RU RU2008101513/15A patent/RU2008101513A/ru not_active Application Discontinuation
- 2008-08-14 CL CL2008002406A patent/CL2008002406A1/es unknown
- 2008-08-14 CL CL2008002407A patent/CL2008002407A1/es unknown
-
2010
- 2010-02-25 JP JP2010040716A patent/JP5378270B2/ja active Active
- 2010-09-28 AU AU2010224456A patent/AU2010224456B9/en active Active
- 2010-10-08 JP JP2010228787A patent/JP5038477B2/ja active Active
-
2011
- 2011-08-08 JP JP2011172951A patent/JP5572133B2/ja active Active
-
2012
- 2012-10-22 HK HK12110485.7A patent/HK1169802A1/xx unknown
-
2017
- 2017-12-14 HR HRP20171944TT patent/HRP20171944T1/hr unknown
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
UY28431A1 (es) | Peliculas que se disuelven por via oral | |
CL2004000931A1 (es) | Pelicula consumible adaptada para adherirse y disolverse en la cavidad bucal que comprende un almidon modificado y un agente farmaceuticamente activo. | |
AR053731A1 (es) | Aromatizacion de gomas de mascar que contienen farmacos | |
ES2422655T3 (es) | Formulaciones de liberación inmediata potenciadas de topiramato | |
AR044077A1 (es) | Peliculas consumibles por via oral que se disuelven rapidamente, que contienen un edulcorante | |
AR058175A1 (es) | Composiciones farmaceuticas solidas que contienen pregabalina | |
AR047841A1 (es) | Metodos y composiciones para el tratamiento de transtornos inmunoinflamatorios | |
AR060739A1 (es) | Composiciones orales que comprenden polimeros de siloxano | |
ECSP066534A (es) | Formas de dosificacion de oxicodona de liberacion controlada, orales, una vez al dia | |
AR037592A1 (es) | Formulaciones farmaceuticas de 5,7,14-triazatetraciclo (10.3.1.02,11.04,9)-hexadeca-2(11),3,5,7,9-pentaeno | |
ECSP044967A (es) | Formulaciones de deposito oftalmicas para administracion periocular o subconjuntival | |
CO6331425A2 (es) | Composiciones que comprenden n-(3,4-difluoro-2-(2-fluoro-4-yodofenilamino)6-metoxifenil)-1-(2,3-dihidroxiproxipropil)ciclopropan-1-sulfamida | |
ECSP066553A (es) | Formas de administración masticables, no comprimidas dosificadas individualmente. | |
AR055838A1 (es) | Formulaciones para microproyecciones recubiertas que tienen solubilidad controlada | |
AR071850A1 (es) | Gomas de mascar en forma de tableta | |
CY1113462T1 (el) | Μορφη δοσολογιας περιεχουσα παντοπραζολη ως δραστικο συστατικο | |
AR059357A1 (es) | Formulaciones farmaceuticas | |
CO7071123A2 (es) | Formulaciones basadas en dispersiones solidas | |
CL2012000169A1 (es) | Composicion farmaceutioca de jarabe que comprende omeprazol o una sal del mismo, un agente solubilizante, un agente basificante, o un tampon, un edulcorente, un aromatizante y un antooxidante; metodo de preparacion; kit que comprende a la formulacion. | |
AR053144A1 (es) | Composicion farmaceutica solida que comprende telitromicina | |
ECSP003685A (es) | Formulaciones orales de liberacion controlada | |
AR037496A1 (es) | Uso novedoso del 2-[5-(4-fluorofenil)-3-piridilmetilaminometil]-cromano y sus sales fisiologicamente aceptables | |
AR040764A1 (es) | Formulaciones farmaceuticas de epinastina, pseudoefedrina y metilefedrina | |
AR046665A1 (es) | Formulaciones orales de desoxipeganina y sus usos | |
CL2006002620A1 (es) | Composicion para la prevencion y tratamiento de infecciones causadas por coccidia en animales que consiste en yema con inmunoglobulas anti-eimeria, agua y un conservador; y metodo para la prevencion de infecciones causadas por parasitos coccidia que comprende la administracion oral de una o mas inmunoglobulinas anti eimeria. |